News for Merck & Co., Inc. (MRK)

We recently compiled a list of the 10 Most Undervalued US Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Merck & Co., Inc.

Investors with a lot of money to spend have taken a bullish stance on Merck & Co MRK. And retail traders should know. We noticed this today when the trades sh...

PRT3789 has demonstrated clinical proof-of-concept that selectively degrading SMARCA2 is generally safe and has monotherapy anti-tumor activity in patients with

ROCHESTER, N.Y., March 07, 2025 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (OTC:VCNX) (

Merck (MRK) closed at $94 in the latest trading session, marking a +0.87% move from the prior day.

**media[559681]**

Merck (MRK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

We recently compiled a list of the 12 Undervalued Wide Moat Stocks to Buy According to Analysts.

Moderna (MRNA) stock in focus as the company aims a 2027 marketing nod for Merck (MRK) partnered skin cancer vaccine. Read more here.

Stocks Analysis by Investing.com (Jesse Cohen) covering: Tyson Foods Inc, Nextera Energy Inc, Procter & Gamble Health Ltd. Read Investing.com (Jesse Cohen)'s latest article on Investing.com

Merck (MRK) stock trended lower as Halozyme (HALO) challenges the company over injectable Keytruda patents. Read more here.

We recently published a list of 10 Best Immunology Stocks To Buy Now. In this article, we are going to take a look at where Merck & Co., Inc.

Preparations for submission of a Biologics License Application (BLA) for Cylembio® (imsapepimut and etimupepimut, adjuvanted) to FDA by year end 2025 remain on

We recently compiled a list of the 12 Best Psychedelic Stocks to Buy in 2025. In this article, we are going to take a look at where Merck & Co., Inc.

In light of potential tariff threats from President Donald Trump, Pfizer Inc.'s (PFE.N) CEO Albert Bourla has suggested the possibility of shifting the company's overseas manufacturing to its U.S. facilities.

Start Time: 14:30 January 1, 0000 3:05 PM ETMerck & Co., Inc.

**media[556056,556057]**

BURLINGTON, Mass., March 03, 2025 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. ( NEUP) (Neuphoria or Company), ”), a clinical-stage biotechnology develop

Enrollment on track in Phase 2 pivotal portion of PYNNACLE clinical trial evaluating rezatapopt as monotherapy in patients with TP53 Y220C and KRAS wild-type ad